Anders Pedersen


Anders Pedersen joined Galecto Biotech in 2013 as Chief Operating Officer. Here he is responsible for managing the project portfolio and the collaboration with service providers. Previously, he served as senior vice president of development at CMC Biologics.

Anders has more than 25 years of experience in the biopharmaceutical industry. His background experience is in process development and discovery of biopharmaceuticals. Prior to CMC Biologics, he spent 13 years at Novo Nordisk. He was a cofounder of ProFound Pharma, which was later acquired by Maxygen.

Anders also served as vice president of project and portfolio management at Life Cycle Pharma and Chief Operating Officer at Recepticon. He has a degree in Chemical Engineering from Danish Technical University in Copenhagen.